Allergan Joins TriNetX to Access Network of Real-World Data

Allergan, a global pharmaceutical company, has joined the TriNetX global research network in hopes to gain real-time access to patient populations in order to determine protocol feasibility, cohort analysis, and site identification. With TriNetX, Allergan is hoping that their researchers will be able to optimize the clinical trial design process and conduct observational studies with more speed and ease.

Read the full release here.